← Leaderboards
Phillip Keith Peterson
Minneapolis Medical Research Fdn, Inc.
$6,937,423
Attributed
$6,937,423
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–08$2M$1.5M$1M$500K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$6,937,423 · 3
By mechanism
R01$5,966,247 · 2
T32$971,176 · 1
Top collaborators
No co-investigators on record.
Most similar at Minneapolis Medical Research Fdn, Inc.
Same institution · by research overlap
- Hamid Rabb$12,872,173
- Joan E. Bechtold$3,482,067
- Karen L Margolis$4,944,205
- Anne M Murray$30,908,651
- Paul Pentel$17,546,958
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureHuman Immunodeficiency Virus 1MorphineImmunomodulatorsEndogenous OpioidMicrogliaOpioid ReceptorNeurotoxinsLaboratory MouseAids /Hiv NeuropathyAids Dementia ComplexAstrocytesDynorphinsInhibitor /AntagonistCocaineClinical ResearchEnzyme Linked Immunosorbent AssayGene ExpressionChemokineCellular ImmunityCytokineHiv InfectionsGliaNeurons
Grant awards (24)
Dynorphin and Glial Cell Immunomodulation$312,566
R01 · FY2008 · DA · contact PI
Modulation of Cell-Mediated Immune Function by Opiates$480,641
R01 · FY2007 · DA · contact PI
Dynorphin and Glial Cell Immunomodulation$318,945
R01 · FY2007 · DA · contact PI
Modulation of Cell-Mediated Immune Function by Opiates$483,853
R01 · FY2006 · DA · contact PI
Dynorphin and Glial Cell Immunomodulation$328,471
R01 · FY2006 · DA · contact PI
Infectious Disease Training in Clinical Investigation$252,234
T32 · FY2006 · AI · contact PI
Modulation of Cell-Mediated Immune Function by Opiates$288,203
R01 · FY2005 · DA
Infectious Disease Training in Clinical Investigation$272,401
T32 · FY2005 · AI
Dynorphin and Glial Cell Immunomodulation$184,810
R01 · FY2005 · DA
Modulation of Cell-Mediated Immune Function by Opiates$158,566
R01 · FY2005 · DA
Dynorphin and Glial Cell Immunomodulation$117,589
R01 · FY2005 · DA
Modulation of Cell-Mediated Immune Function by Opiates$433,759
R01 · FY2004 · DA
Dynorphin and Glial Cell Immunomodulation$301,740
R01 · FY2004 · DA
Infectious Disease Training in Clinical Investigation$223,073
T32 · FY2004 · AI
Modulation of Cell-Mediated Immune Function by Opiates$421,124
R01 · FY2003 · DA
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION$265,914
R01 · FY2003 · DA
Infectious Disease Training in Clinical Investigation$223,468
T32 · FY2003 · AI
MODULATION OF CELL-MEDIATED IMMUNE FUNCTION BY OPIATES$364,479
R01 · FY2002 · DA
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION$258,168
R01 · FY2002 · DA
MODULATION OF CELL-MEDIATED IMMUNE FUNCTION BY OPIATES$50,428
R01 · FY2002 · DA
MODULATION OF CELL-MEDIATED IMMUNE FUNCTION BY OPIATES$355,741
R01 · FY2001 · DA
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION$250,647
R01 · FY2001 · DA
MODULATION OF CELL-MEDIATED IMMUNE FUNCTION BY OPIATES$347,257
R01 · FY2000 · DA
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION$243,346
R01 · FY2000 · DA